Vanda Pharmaceuticals
$13.599876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$13.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.06 (-0.44%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell VNDA and other stocks, options, ETFs, and crypto commission-free!
About VNDA
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Read More Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
Employees
270
Headquarters
Washington, District of Columbia
Founded
2002
Market Cap
723.99M
Price-Earnings Ratio
26.22
Dividend Yield
0.00
Average Volume
614.48K
High Today
$13.93
Low Today
$13.36
Open Price
$13.82
Volume
534.61K
52 Week High
$33.44
52 Week Low
$11.83
Collections
Price Paid on Robinhood
30% Lower
Right Now
52 Week Low
$13.88
Average Price Paid
$19.40
52 Week High
$33.44
Analyst Ratings
50%
of 6 ratings
Buy
50%
Hold
50%
Sell
0%
VNDA Earnings
-$0.18
-$0.03
$0.13
$0.28
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 6, After Hours